|Acquired by||Atlantic Bone Screen|
|Phone||33 2 40 41 29 61|
Atlanchim Pharma operates as a biotechnology company. The company offers services in the areas of research collaboration, including consultancy, bibliographical studies, elaboration of synthesis schemes, improvement in synthesis routes, and customized solutions; fine chemicals, including enantioselective synthesis, nitrogen, sulphur heterocycles synthesis, aminoacids, nucleic acids, steroids, and alkaloid synthesis; and biological validation of synthetized molecules, including in vitro screening and in vivo pharmacological evaluation. It also provides site-specific stable isotope labeling services. The company was founded in 2004 and is based in Nantes, France. As of April 30, 2008, Atlanchim Pharma operates as a subsidiary of Atlantic Bone Screen Company.